Vanderbilt University lowered its stake in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 0.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 104,570 shares of the real estate investment trust’s stock after selling 971 shares during the period. Vanderbilt University’s holdings in Healthpeak Properties were worth $2,120,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. HM Payson & Co. bought a new position in Healthpeak Properties in the 3rd quarter valued at about $25,000. S.A. Mason LLC acquired a new stake in shares of Healthpeak Properties during the 3rd quarter worth approximately $26,000. Rise Advisors LLC bought a new position in Healthpeak Properties in the third quarter valued at approximately $29,000. Fortitude Family Office LLC acquired a new position in Healthpeak Properties during the third quarter valued at approximately $32,000. Finally, Barrett & Company Inc. bought a new stake in Healthpeak Properties during the third quarter worth $33,000. Institutional investors and hedge funds own 93.57% of the company’s stock.
Healthpeak Properties Stock Performance
Shares of Healthpeak Properties stock opened at $20.07 on Thursday. The stock has a market cap of $14.03 billion, a price-to-earnings ratio of 42.69, a P/E/G ratio of 2.22 and a beta of 1.15. Healthpeak Properties, Inc. has a twelve month low of $16.01 and a twelve month high of $23.26. The company’s fifty day moving average is $20.63 and its 200 day moving average is $21.53. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.93.
Healthpeak Properties Increases Dividend
Analysts Set New Price Targets
Several brokerages have recently issued reports on DOC. Mizuho decreased their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Thursday, December 5th. Morgan Stanley upgraded Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price on the stock in a research report on Wednesday, January 15th. StockNews.com cut shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Wednesday, October 30th. Royal Bank of Canada lifted their price target on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and increased their price objective for the company from $20.00 to $28.00 in a research note on Monday, October 21st. One analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $24.15.
Read Our Latest Stock Report on DOC
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories
- Five stocks we like better than Healthpeak Properties
- With Risk Tolerance, One Size Does Not Fit All
- 3 Must-Have ETFs Set to Dominate This Quarter
- Following Congress Stock Trades
- Seeking Stability? These 3 Stocks Offer Strong Potential
- What is the NASDAQ Stock Exchange?
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.